ALK-Positive Large B-Cell Lymphoma

Explore clinical trials studying ALK-Positive Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

ALK-Positive Large B-Cell Lymphoma trial results

Recruiting

NCT04231877

Conditions: ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Recruiting

NCT05544019

Conditions: ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations: Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States

Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States

Napa Research Pompano Beach, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 36 locations

Active, Not Recruiting

NCT03038672

Conditions: ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +53 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Moffitt Cancer Center-International Plaza Tampa, Florida, United States

View all 33 locations